43 trends tracked about this subject — the full history, oldest to newest below.
A former Eli Lilly sales representative has filed a retaliation lawsuit alleging she was fired for objecting to Mounjaro marketing.
Two case reports describe men who developed psychosis after stopping tirzepatide, adding to questions about the psychiatric effects of discontinuing GLP-1 drugs.
Recent coverage examines nutritional deficiencies linked to weight-loss injections and highlights the importance of protein intake.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
19 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Recent studies indicate that popular GLP-1 weight-loss medications like Ozempic and Mounjaro may also slow biological aging.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical and lifestyle experts are questioning the long-term safety and efficacy of GLP-1 medications as they transition from clinical tools to consumer drugs.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
New reports warn that discontinuing GLP-1 weight-loss medications like Ozempic, Mounjaro, and Wegovy may increase the risk of heart attack and stroke.
Major drugmakers Novo Nordisk and Eli Lilly face numerous lawsuits alleging popular GLP-1 medications cause sudden vision loss.
New research indicates GLP-1 weight-loss medications like Mounjaro and Zepbound may offer therapeutic benefits for the one billion people with sleep apnea.
A new experimental weight loss injection has outperformed Mounjaro in a recent study, signaling a potential shift in obesity treatment.
Recent studies indicate that GLP-1 weight loss medications may worsen or accelerate hair loss in men.
A growing cultural and medical debate is emerging over the use of GLP-1 medications, focusing on the tension between clinical benefits and social stigma.
Concerns grow over the 'microdosing' of GLP-1 weight-loss medications as reports emerge regarding their effectiveness at low doses and long-term maintenance.
Mounting evidence highlights potential health benefits linked to the Shingrix vaccine, according to recent media coverage.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Experts call for safer weight loss methods as public and medical attention intensifies around the use and effectiveness of GLP-1 medications.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Regulators receive hundreds of reports linking popular weight-loss drugs to deaths.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Medical reports highlight emerging cosmetic and physical side effects linked to rapid weight loss from GLP-1 receptor agonist medications.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Amy Schumer shares unfiltered bikini photos from a yacht trip, highlighting her weight loss progress after a year on Mounjaro.
Australian regulators and medical reports link GLP-1 weight-loss drugs like Ozempic to a rare and severe risk of permanent vision loss.
New research links GLP-1 weight-loss medications like Ozempic and Mounjaro to an increased risk of hair loss in patients.
Pharmacists are issuing heatwave-related usage warnings for a wide range of medications as temperatures rise in England and Wales.